Childhood Acute Immune Thrombocytopenic Purpura: 20 Years Later

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 6, 2003, Pages 605-617

  Blanchette, Victor S ^a,b   Carcao, Manuel ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute ITP; Anti D; Bleeding; Children; Corticosteroids; Immunoglobulin; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MEPREDNISONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RHESUS D ANTIBODY; VIRUS VACCINE;

BEHAVIOR DISORDER; BONE MARROW BIOPSY; BRAIN HEMORRHAGE; CAPILLARY RESISTANCE; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; DIZZINESS; FEVER; GLUCOSURIA; HEADACHE; HOSPITALIZATION; HUMAN; HYPERACTIVITY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NAUSEA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; EMERGENCIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; INFANT; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 0347991756     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815628     Document Type: Review

References (58)

1. Imbach P, Barandun S, d'Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;i:1228-1231
2. Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells? Lancet 1983;ii:193-195
3. Zuelzer WW, Lusher JM. Childhood idiopathic thrombocytopenic purpura. To treat or not to treat. Am J Dis Child 1977;131:360-362
4. Kühne T, Imbach P, Bolton-Maggs PHB, Berchtold W, Blanchette V, Buchanan GR, for the Intercontinental ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001;358:2122-2125
5. Lusher JM, Zuelzer WW. Idiopathic thrombocytopenic purpura in childhood. J Pediatr 1966;68:971-979
6. Choi SI, McClure PD. Idiopathic thrombocytopenic purpura in childhood. Can Med Assoc J 1967;97:562-568
7. Blanchette VS. Unpublished observations
8. Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. New Engl J Med 1966;275:352-356
9. Miller E, Waight P, Farrington P, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001;84:227-229
10. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40
11. Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulin or sustained prednisone treatment. J Pediatr 2000;137:629-632
12. Imbach P, Akatsuka J, Blanchette V, et al. Immunocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 1995;154(suppl 3):S60-S64
13. Iyori H, Bessho F, Ookawa H, et al, for the Japanese Study Group on childhood ITP. Intracranial hemorrhage in children with immune thrombocytopenic purpura. Ann Hematol 2000;79:691-695
14. Lilleyman JS, on behalf of the Paediatric Haematology Forum of the British Society of Haematology. Intracranial hemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child 1994;71:251-253
15. Woerner SJ, Abildgaard CF, French BN. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 1981;67:453-460
16. Blanchette VS, Turner C. Treatment of acute idiopathic thrombocytopenic purpura. J Pediatr 1986;108:326-327
17. Bolton-Maggs PHB, Dickerhoff R, Vora AJ. The nontreatment of childhood ITP (or "The art of medicine consists of amusing the patient until nature cures the disease"). Semin Thromb Hemost 2001;27:269-275
18. Lee MS, Kim WG. Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: report of seven patients and a meta-analysis. Neurology 1998;50:1160-1163
19. De Mattia D, Del Principe D, Del Vecchio GC, et al, and The AIEOP ITP Study Group. Acute childhood idiopathic thrombocytopenic purpura: AIEOI concensus guidelines for diagnosis and treatment. Haematologica 2000;85:420-424
20. Working Party of the British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-596
21. Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol 1999;105:871-875
22. Sartorius JA. Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am J Pediatr Hematol Oncol 1984;6:165-169
23. Buchanan GR, Holtkamp CA. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial. Am J Pediatr Hematol Oncol 1984;6:355-361
24. Özsoylu S, Irken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol 1989;42:431-435
25. Özsoylu S, Sayli TR, Ozturk G. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 1993;10:317-321
26. Gereige RS, Barrios NJ. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both. P R Health Sci J 2000;19:15-18
27. Suarez CR, Rademaker D, Hasson A, Mangogna L. High-dose steroids in childhood acute idiopathic thrombocytopenia purpura. Am J Pediatr Hematol Oncol 1986;8:111-115
28. van Hoff J, Ritchey AK. Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura. J Pediatr 1988;113:563-566
29. Jayabose S, Patel P, Inamdar S, Brillian R, Mamtani R. Use of intravenous methylprednisolone in acute idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol 1987;9:133-135
30. Carcao MD, Zipursky A, Butchart S, Leaker M, Blanchette VS. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr 1998;S424:71-74
31. Imbach P, Wagner HP, Berchtold W, et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 1985;ii:464-468
32. Blanchette VS, Luke B, Andrew M, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989-995
33. Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-707
34. Khalifa AS, Tolba KA, El-Alfy MS, Gadallah M, Ibrahim FH. Idiopathic thrombocytopenic purpura in Egyptian children. Acta Haematol 1993;90:125-129
35. Albayrak D, Islek I, Kalayci AG, Gürses N. Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr 1994;125:1004-1007
36. Rosthoj S, Nielsen S, Pedersen FK, and the Danish ITP Study Group. Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Acta Paediatr 1996;85:910-915
37. Warrier I, Bussel JB, Valdez L, Barbosa J, Beardsley DS, and the Low-Dose IVIG Study Group. Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 1997;19:197-201
38. Fujisawa K, Iyori H, Ohkawa H, et al, for the Japanese Study Group on Childhood ITP. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. Int J Hematol 2000;72:376-383
39. Ancona KG, Parker RI, Atlas MP, Prakash D. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2002;24:540-544
40. Duru F, Fisgin T, Yarali N, Kara A. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy. Pediatr Hematol Oncol 2002;19:219-225
41. Eden OB, Lilleyman JS, on behalf of the British Paediatric Haematology Group. Guidelines for management of idiopathic thrombocytopenic purpura. Arch Dis Child 1992;67:1056-1058
42. Scaradavou A, Woo B, Woloski BMR, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997;89:2689-2700
43. Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ. Treatment of chilhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immunoglobulin. J Pediatr 1999;134:21-26
44. Newman GC, Nova MV, Fodero EM, Lesser ML, Woloski BMR, Bussel JB. A dose of 75 μg/kg/d of IV anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001;112:1076-1078
45. Gaines AR. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000;95:2523-2529
46. Baumann MA, Menitova JE, Aster RH, Anderson T. Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion. Ann Intern Med 1986;104:808-809
47. Bolton-Maggs PHB, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997;350:620-623
48. Dubansky AS, Oski FA. Controversies in the management of acute idiopathic thrombocytopenic purpura: a survey of specialists. Pediatrics 1986;77:49-52
49. Vesely S, Buchanan GR, Cohen A, Raskob G, George J. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura. Results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol 2000;22:55-61
50. Dubansky AS, Boyett JM, Falletta J, et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: A rare event in a Pediatric Oncology Group Study. Pediatrics 1989;84:1068-1071
51. Calpin C, Dick P, Poon A, Feldman W. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adol Med 1998;152:345-347
52. Halperin DS, Doyle JJ. Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child 1988;142:508-511
53. Vesely SK, Buchanan GR, Leah A, et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003;25:130-133
54. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 2001;27:253-267
55. Buchanan GR, Adix L. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura. Semin Thromb Hemost 2001;27:277-285
56. Buchanan G, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002; 141:683-688
57. Barnard D, Woloski M, Feeny D, et al, for the Canadian Children's Platelet Study Group. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol 2003;25:56-62
58. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr 1998;133:334-339